Latest Warrants News

S2 Resources reports encouraging gold-arsenic anomalies from reconnaissance drilling at its Yeungroon project in Victoria, while drilling at Glenlogan in NSW faces delays. Assays from Fosterville are awaited, underscoring a busy exploration pipeline.

Lunnon Metals has revealed promising results from sterilisation drilling near its Lady Herial gold deposit, uncovering a new stacked gold structure that could expand resource potential.

Locate Technologies has secured $1.45 million through a share placement and established a $2 million At-the-Market facility to boost financial flexibility, while unveiling a strategic plan to hold Bitcoin as part of its treasury management.

Australasian Metals Limited has identified significant chargeability anomalies at its May Queen Gold Project, suggesting promising sulphide mineralisation and supporting previous drilling results. The company plans targeted drilling to validate these new geophysical targets.

Euro Manganese has successfully closed a C$11.2 million financing round, attracting heavyweight investors including the European Bank for Reconstruction and Development and Eric Sprott. The funds will accelerate development of its Chvaletice Manganese Project, a critical European source of battery-grade manganese.

Bendigo and Adelaide Bank reported a slight dip in its Common Equity Tier 1 ratio to 10.83% for the March 2025 quarter, reflecting dividend payments and increased residential lending. Despite this, the bank sustained robust liquidity and funding metrics well above regulatory minimums.

betr Entertainment has successfully closed the retail portion of its $130 million equity raise, securing funds to advance its strategic acquisition of PointsBet Holdings.

Mayne Pharma has clarified why it did not disclose an FDA Untitled Letter to the market despite sharing it with its scheme bidder, reaffirming compliance with ASX rules amid recent share price volatility.

Chimeric Therapeutics has raised $6.6 million through a discounted two-tranche placement to accelerate its promising CAR-T and NK cell therapy clinical programs. The capital raise, strongly backed by institutional and professional investors, signals growing confidence in the company’s oncology pipeline.

Almonty Industries posted a modest revenue rise in Q1 2025 but faced a steep net loss due to warrant revaluation, while securing key U.S. defense contracts and advancing its flagship Sangdong tungsten mine.

Codrus Minerals has raised $1.24 million to fund drilling at its Bull Run Gold Project in Oregon, with operations set to begin by the end of May. The company targets six high-priority gold zones backed by strong assays and historic drill results.

Gentrack Group Limited reported a solid 9.8% revenue increase and a 34.7% jump in net profit for the first half of 2025, yet opted against paying an interim dividend.